Form 4: Indaptus Therapeutics Director Cancels Stock Options, Receives $500 Consideration
SEC Form 4 Filing
Roger Pomerantz, a director at Indaptus Therapeutics, canceled stock options by mutual agreement with the company, receiving $500 in consideration.
Summary
- Roger Pomerantz, a director of Indaptus Therapeutics, Inc. (INDP), filed a Form 4 detailing changes in beneficial ownership.
- On April 10, 2025, Pomerantz canceled three stock option grants by mutual agreement with the company.
- The options had exercise prices of $24.60, $388.64, and $355.20, and were originally granted on July 15, 2020, June 28, 2019, and June 28, 2018, respectively.
- As consideration for the cancellation, Pomerantz received a total of $500 from Indaptus Therapeutics.
- Following the transaction, Pomerantz holds zero derivative securities.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing a transaction. The sentiment is neither positive nor negative.
Industry Context
This filing is a routine disclosure of insider transactions and doesn't necessarily reflect broader industry trends. However, option cancellations can sometimes indicate a change in company strategy or executive compensation.
Stakeholder Impact
- The cancellation of stock options and the $500 payment could have a minor impact on the company's financials.
Key Dates
| Date | Description |
|---|---|
| 06/28/2018 | Original grant date of one of the canceled stock options. |
| 06/28/2019 | Original grant date of one of the canceled stock options. |
| 07/15/2020 | Original grant date of one of the canceled stock options. |
| 04/10/2025 | Date of stock option cancellation. |
| 04/11/2025 | Date of signature on the Form 4. |
Keywords
Form 4, Indaptus Therapeutics, Stock Options, Roger Pomerantz, Beneficial Ownership, Cancellation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.